-
A forum to discuss or ask questions about a blood based 12-miRNA signature of Alzheimer patients - GSE46579.
1
question or discussion
-
A forum to discuss or ask questions about a double-blind, randomised, placebo-controlled, parallel-group dose-ranging study
1
question or discussion
-
A forum to discuss or ask questions about a Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease
1
question or discussion
-
A forum to discuss or ask questions about a Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the H3 Receptor Antagonist, GSK239512 in Subjects with Mild to Moderate Alzheimer's Disease.
1
question or discussion
-
A forum to discuss or ask questions about a Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients with Alzheimer
1
question or discussion
-
A forum to discuss or ask questions about a reference induced pluripotent stem cell line for large-scale collaborative studies
3
questions and discussions
-
A forum to discuss or ask questions about a Single Blind, Placebo-controlled, Randomised Study in Mild to Moderate Alzheimer's Disease Patients to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK239512, a Selective Histamin
1
question or discussion
-
A forum to discuss or ask questions about the Study of Semagacestat for Alzheimer's Patients.
1
question or discussion
-
A forum to discuss or ask questions about the AD Synthetic Patient Data.
1
question or discussion
-
2
questions and discussions
-
A forum to discuss or ask questions about an Open Label Single Oral Dose Study in Patients with Mild Alzheimer's Disease to Assess the Pharmacokinetics of Extended-Release Formulation of Rosiglitazone (RSG XR) in This Population
1
question or discussion
-
A forum to discuss or ask questions about an Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
0
questions and discussions
-
A forum to discuss or ask questions about an open-label extension to study AVA100193
0
questions
-
A forum to discuss or ask questions about an open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended-release tablets) in subjects with mild to moderate Alzheimer's disease
1
question or discussion
-
A forum to discuss or ask questions about an Open-label Extension to Study AVA102670 and AVA102672, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended-Release Tablets) as Adjunctive Therapy on Cognition in Subjects with Mild to Moderate
1
question or discussion
-
A forum to discuss or ask questions about an Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended-Release Tablets) on Cognition in Subjects with Mild to Moderate Alzheimer's Disease.
1
question or discussion
-
A forum to discuss or ask questions about the Banner API Generation 1 and 2 studies.
0
questions and discussions
-
A forum to discuss or ask questions about BLSA Open Data.
0
questions
-
A forum to discuss or ask questions about BLSA Synthetic Data.
0
questions
-
A forum to discuss or ask questions about the brain Imaging Study of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
1
question or discussion
